Clene Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.16

-0.18 (-2.84%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 91%

Hold 1 9%

Sell 0 0%

Price Target

Analyst Price Target +206.4% upside

Low Target $15.04

Average Target $18.86

High Target $28.67

Current Price $6.16

Current
$6.16

Target
$18.86

$15.04 $18.86 avg $28.67

Scenario Analysis

Bear Case

$15.04

144.4%

Low target

Base Case

$18.86

+206.4%

Avg target

Bull Case

$28.67

+365.8%

High target

Risk/Reward

2.5x

Favorable

Price in Context

52-Week High

$13.50

-54.4% from high

52-Week Low

$3.25

+89.4% from low

Target vs 52W High

$18.86

+39.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%